GlaxoSmithKline Consumer Healthcare Pakistan Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was PKR 16,316.744 million compared to PKR 14,875.267 million a year ago. Operating income was PKR 1,892.143 million compared to PKR 1,688.497 million a year ago. Net income was PKR 1,257.518 million compared to PKR 1,074.551 million a year ago. Basic earnings per share was PKR 10.74 compared to PKR 9.18 a year ago.